WASHINGTON, Aug. 23 -- The Parenteral Drug Association, Bethesda, Maryland, has submitted a public comment letter to the Food and Drug Administration (FDA) highlighting various recommendations regarding the agency's draft guidance on the ICH Q1 Guideline for Stability Testing of Drug Substances and Drug Products. The guidance, aimed at streamlining stability testing protocols for the pharmaceutical industry, is crucial for ensuring drug quality over time. PDA's feedback emphasizes that the prop  more